Pharmaceuticals

Global HP (High Potency) APIs Market Overview And Prospects

December 8, 2021 by The Business Research Company

Learn about the global HP API market through The Business Research Company, which provides information on HP APIs market size, HP APIs market drivers and restraints, HP APIs market players, the COVID-19 impact on the HP APIs market, and more.

Our annual holiday sale is here! Get your discounted market research reports today.

The global high potency API market is expected to grow from $19.27 billion in 2020 to $20.3 billion in 2021 at a compound annual growth rate (CAGR) of 5.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The high potency active pharmaceutical ingredients (HPAPI) market is expected to reach $27.3 billion in 2025 at a CAGR of 7.7%.

The rising number of cancer cases coupled with increasing sales of cancer drugs is expected to drive innovation in HP APIs manufacturing, thus driving the market during the forecast period.

Request A Sample For The Global HP (High Potency) APIs Market Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2814&type=smph

The high potency APIs (HPAPI) market consists of sales of high potency active pharmaceutical ingredients and related services. High potency APIs are extremely effective in pharmacologically active ingredients. These are highly specific in their action and offer significant efficiency even at the low daily therapeutic doses. HPAPIs are used in formulations for high potent drugs, owing to their ability to target precise disease cells including cancer cells.

Global HP APIs market segments include:

By Type: Innovative HPAPI, Generic HPAPI

By Synthesis Type: Synthetic HPAPI, Biotech HPAPI

By Therapeutic Application: Oncology, Hormonal Disorder, Glaucoma, Other Therapeutic Applications (Respiratory Disorders, CVD, Diabetes, Cosmetology, And Erectile Dysfunction)

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

The companies dealing in the high potency APIs market are focusing on strategies such as production facility expansion and mergers & acquisitions to maintain their position in the competitive business environment.

TBRC’s HP APIs market report covers:

Major Market Players: Eli Lily and Company, Novartis AG, Bristol-Myers Squibb Company, Roche Diagnostics Ltd., Sanofi, Hospira Inc., BASF SE, Covidien plc, Boehringer Ingelheim GmbH and Merck & Co. Inc.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The HP (High Potency) APIs Global Market Report 2021: COVID-19 Growth and Change to 2030 is one of a series of new reports from The Business Research Company that provides HP APIs market overviews, analyzes and forecasts market size, share, HP APIs market players, HP APIs market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s HP APIs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Pharmaceutical Drugs And Biologics Logistics Market 2021

COVID-19 Drug Associated APIs Global Market Report 2021

Pharmaceutical API Manufacturing Global Market Report 2021

Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Check out our Blog: https://blog.tbrc.info/

Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model